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Abstract 
Interaction of α-adrenergic stress and integrin-mediated signal transduction  
in hypertrophic cardiac myocytes 
 
Kihyun Byun 
 
Department of Medicine  
The Graduate School, Yonsei University 
 
(Directed by Professor Namsik Chung)  
 
In cardiac myocytes, stimulation of alpha (1)-adrenoceptor (AR) leads to a 
hypertrophic phenotype. The Gh protein (transglutaminase II, TGII) is a tissue type 
transglutaminase and transmits the alpha (1B)-adrenoceptor signal with GTPase 
activity. Recent evidence suggests that integrin activation, in concert with G 
proteins activation, might be essential for cardiomyocyte growth. In this study, our 
objectives were to evaluate how Gh and integrin interact to promote cardiomyocyte 
hypertrophy and to identify Gh molecular determinants and downstream signals 
involved. First, we observed the selectivity of alpha-adrenoceptors in 
norepinephrine (NE)-induced cardiac hypertrophy by protein synthesis and 
estimation of constitutive gene, MLC-2 and MHC. NE-mediated hypertrophic 
responses activated ERK1, 2 and their upstream regulators MEK1,2, which were 
inhibited by siRNA for Gh. We also identified significant activation of β1-integrin 
in NE-induced cardiomyocyte hypertrophy. In addition, FAK and Shc, regulator of 
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FAK, were directly related with integrin and Gh protein in NE-induced 
cardiomyocyte hypertrophy. The activation of FAK and Shc were suppressed by 
siRNA for Gh. In conclusion, the hypertrophic response induced by norepinephrine 
in cardiomyocytes occurs through β1 Integrin/Shc/FAK/MEK1, 2/ ERKs signal 
pathways via α1-AR/Gh. 
___________________________________________________________________ 
Key Words : cardiac myocyte: hypertrophy: integrin: α-adrenoeceptor 
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I. INTRODUCTION 
Human cardiac hypertrophy is a general pathological condition that often 
develops as a by-product of hypertension or valvular heart disease. Adult 
cardiomyocytes have no capacity to divide, but respond to stress and growth stimuli 
by enlarging.1 Cardiac hypertrophy is a compensatory process that occurs in 
pathological conditions such as hypertension, myocardial infarction, and some 
genetic heart diseases, and is related to an increased risk of cardiac arrhythmias, 
diastolic dysfunction, congestive heart failure, and death2, 3. 
The relationship between increased adrenergic activity and cardiac hypertrophy 
has been documented for some time but the mechanisms involved have not been 
clearly understood until recently. The hypertrophic effect of α1-adrenergic agonists 
has been observed in cultured cardiomyocytes from both neonates and adults. The 
direct parameters related to cardiac hypertrophy in cultured cardiocytes are 
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increased cell size and the protein content. Norepinephrine is a direct hypertrophic 
effector in cardiac myocytes without affecting afterload.4, 5, 6 The mechanisms by 
which norepinephrine induces cardiomyocyte hypertrophy are as yet controversial. 
Norepinephrine-mediated adrenoceptor (AR) are divided into two major subtypes: 
α and β. The specific response mediated by these ARs has not been confirmed.  
The α1-ARs, but not the α2-ARs, exist in cardiomyocytes and α1-ARs have been 
implicated in the pathogenesis of cardiac hypertrophy, in ischemia-induced cardiac 
arrhythmias, and ischemic preconditioning.7 Norepinephrine, epinephrine and 
catecholamines activate α1-ARs that are members of G-protein coupled receptor 
(GPCR) superfamily.8 The specific G proteins that couple α1-ARs to their 
intracellular effectors and the specificity of the various α1-ARs subtypes for 
different G proteins remain to be clearly defined. 
Whatever the etiology, the development of cardiac hypertrophy and 
progression towards heart failure include hypertrophy of cardiomyocytes, 
hyperplasia of fibroblasts, changes in the composition of interstitial tissue and 
ventricular remodeling.9 Myocardial remodeling implies an alteration in the 
composition and distribution of the extracellular matrix (ECM), as well as changes 
in the spatial orientation of intracellular components and cells. Alterations in the 
density and distribution of the major constituents of the muscle cytoskeleton, i.e. 
intermediate filaments of desmin, microtubules have been associated with cardiac 
remodeling.10, 11, 12, 13 Other cell types, mainly fibroblasts contribute to the increase 
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in the synthesis and secretion of proteins of the ECM, such as fibronectin (FN), 
laminin, collagen I and III, resulting in cardiac fibrosis.14, 15 The accumulation of 
ECM components both in the myocardium and in the coronary vasculature 
contributes to cardiac failure. The ECM has historically been considered an inert 
fibrous network, but in fact, it exerts a specific regulatory influence on 
morphogenesis, cell function, proliferation, differentiation, and migration. 
According to in vitro analysis, cellular behavior varies according to cell interactions 
with the ECM that depend on trans-membrane proteins, such as integrins, and on a 
sarcolemmal cytoskeleton.16, 17 When activated, integrins, a family of cell surface 
receptors, cluster in focal adhesion sites with cytoskeletal proteins associated to 
sarcolemma, such as vinculin, talin, paxillin and with signaling enzymes (protein-
kinases and GTPases).18 These complexes transmit external changes of the 
environment to the cells, via signaling pathways that include tyrosine 
phosphorylation of proteins, such as paxillin and activation of focal adhesion 
kinases such as FAK, Pyk2, and Src, and serine and threonine kinases; protein 
kinase C (PKC) and mitogen-activated protein kinase (MAPK).   
The possible involvement of these signaling pathways in cardiac remodeling 
associated with hypertrophy and heart failure is strengthened by the fact that, in 
vitro, 1) activation of integrins induces the formation of focal adhesion plaques 19, 
2) the integrin signal can overlap and even be synergic with those of growth factors 
20
, and angiotensin II 21, 22, 23, and 3) integrin signaling pathways may be directly 
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responsive to mechanical forces 24. Insights into integrin mediated signaling 
pathways and regulation in cardiovascular system have been mostly restricted to in 
vitro studies of non-muscle, smooth muscle and endothelial cells. To our 
knowledge, little work has been done at the level of hypertrophic cardiomyocytes. 
The integrins consist of two different chains, α (120-150 kDa) and β (110-190 
kDa), linked by noncovalent bounds that are coded by different genes.25 Integrins 
are associated in multiple ab dimers and differential splicing of cytoplasmic 
domains determine a large variety of combinations. The expression of α and β 
subunits is strictly regulated during development and is cell and ligand specific, 
several integrins can bind the same component of the ECM. The affinity of 
integrins to their ligand is low (Kd 10-6 M), but ligands have a high density (105-106 
molecules per cell). In cardiomyocytes, β1 integrin is localized near the Z lines.26 
The beta 1D isoform is codistributed with vinculin at both costamere and 
intercalated disc levels.27 Mechanical forces stabilize the cellular levels of β1
 
integrin and vinculin, possibly by regulating their association, with the formation 
and maintenance of focal adhesion and costameres.28 Interaction of β1 integrin and 
the ECM is necessary for the differentiation and the maintenance of a specialized 
phenotype of cardiac muscle cells.29 Both integrin ligation and signaling appear to 
be involved in the cardiac hypertrophic response pathway mediated by α-1 
adrenergic agonist. Indeed, adenovirus-mediated overexpression of β1 integrin 
increases the hypertrophic response of neonatal rat ventricular myocytes to 
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catecholamines, and suppression of integrin signaling by over-expression of free β1 
integrin cytoplasmic domain inhibits this response.30 Alternative splicing of the β1 
transcript results in different isoforms that modulate the integrin adhesive functions. 
An integrin β1 A isoform is widely expressed in non-muscle cell types and is 
present in fetal striated muscle cells including cardiomyocytes whereas integrin β1
 
D isoform, is specifically expressed in cardiac and skeletal muscle cells of adult 
mammals. In the neonatal cardiac myocytes, β1 integrin combines with the α1, α3, 
α5, α6 and α7 subunit to mediate attachment to laminin, collagen and fibronectin.31 
In adult, the integrin α7
 
B isoform is the major partner of β1
 
D isoform in the 
cardiomyocytes . On the other hand, the expression of the α1 chain increases 
together with that of collagen during cardiac hypertrophy. 
Recent studies have demonstrated that integrin activation, in concert with G 
protein activation, might be essential for the growth of cardiomyocytes. For 
example, balloon-mediated ventricular stretch of isolated adult rat heart results in 
the rapid activation of FAK, promotes the association of Grb2 with FAK, and 
causes the activation of extra-cellular signal-regulated kinase 1/2 (ERK) . In 
addition, stretch of cultured rat neonatal cardiomyocytes results in the rapid 
activation of FAK and c-Src, the formation of a Grb2-FAK complex, and the 
activation of p38 MAPK 34. Furthermore, expression of an integrin β1 D inhibitor in 
cultured rat neonatal cardiomyocytes blocks phenylephrine-induced hypertrophy 
and atrial natriuretic factor (ANF) expression. 33 Finally, expression of a dominant 
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negative form of FAK, or expression of a mutant form of FAK that is unable to 
bind to Grb2, in cultured cardiomyocytes blocks phenylephrine-induced 
hypertrophy and ERK activation .32, 33 In this study, we tested if Gh activation 
interacts intergrin activation to promote cardiomyocyte hypertrophic responses and 
attempted to identify Gh molecular determinants and potential downstream signals 
involved. 
 
II. MATERIALS AND METHODS  
 
1. Isolation of neonatal rat cardiomyocytes  
 
Neonatal rat cardiomyocytes were isolated and purified using modifications of 
previously described methods. Briefly, hearts of 1-2 day-old Sprague Dawley rat 
pups were dissected, and the ventricles washed with Dulbecco's phosphate-buffered 
saline solution (PBS, pH 7.4, Gibco BRL) lacking Ca2+ and Mg2+. Using micro-
dissecting scissors, hearts were minced until the pieces were approximately 1 mm3 
and treated with 10ml of collagenase I (0.8 mg/ml, 262 units/mg, Gibco BRL) for 
15 minutes at 37°C. The supernatant was then removed and the tissue was treated 
with fresh collagenase I solution for an additional 15 minutes. The cells in the 
supernatant were transferred to a tube containing cell culture medium (α-MEM 
containing 10% fetal bovine serum, Gibco BRL). The tubes were centrifuged at 
1200 rpm for 4 minutes at room temperature, and the cell pellet was resuspended in 
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5 ml of cell culture medium. The above procedures were repeated 7-9 times until 
there little tissue was remained. Cell suspensions were collected and incubated in 
100mm tissue culture dishes for 1-3 hours to reduce fibroblast contamination. The 
non-adherent cells were collected and seeded to achieve a final concentration of 5 x 
105 cells/mL. After incubation for 4-6 hours, the cells were rinsed twice with cell 
culture medium and 0.1 mM BrdU was added. Cells were then cultured in a CO2 
incubator at 37°C.  
 
2. Immunoblot analysis  
 
Treated cells were washed once in PBS and lysed in a lysis buffer (Cell 
signaling, Beverly, MA, USA) containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 
mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β-
glycerophosphate, 1 mM Na3VO4, 1 mg/ml leupeptin, and 1 mM PMSF. Protein 
concentrations were determined using the Bradford protein assay kit (BioRad, 
Hercules, CA, USA). Proteins were separated in a 12% SDS-polyacrylamide gel 
and transferred to PVDF membrane (Millipore Co, Bedford, MA, USA). After 
blocking the membrane with Tris-buffered saline-Tween 20 (TBS-T, 0.1% Tween 
20) containing 5% non-fat dried milk for 1 hr at room temperature, membrane was 
washed twice with TBS-T for 10 min and incubated with primary antibodies for 1 
hr at room temperature or for overnight at 4°C. The membrane was washed three 
 - 10 - 
times with TBS-T for 10 min, and then incubated for 1 hr at room temperature with 
horseradish peroxidase (HRP)-conjugated secondary antibodies. After extensive 
washing, bands were detected by enhanced chemoluminescence (ECL) reagent 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Band intensities were 
quantified using Photo-Image System (Molecular Dynamics, Uppsala, Sweden). 
 
3. RNA interference 
 
For function-blocking experiments, we used small interfering RNA molecules 
(siRNA) targeted at Gh and β1-integrin mRNA. A 21-nt sequence for siRNA was 
derived from the rat Gh (GenBank accession no. GI: 56083) and β1-integrin mRNA 
sequence (GenBank accession no. GI: 24511) and obtained from Ambion, Inc. (TX, 
USA): small interfering RNA against Gh (sense, 5’-
GGGUUACCGGAAUAUCAUCTT-3’; antisense, 5’-GAUGAUAUUCCGGUA 
ACCCTT-3’) and β1-integrin (sense, 5’-CCUGGAAAAUAAUGUGUAUTT-3’; 
antisense, 5’-AUACACAUUAUUUUCCAGGTG-3’). Cardiomyocytes were 
transfected with si-Gh or β1-integrin duplexes by using siPORT NeoFX (Ambion 
Inc.). Briefly, RNA duplex (10nM of final concentration) was incubated in serum-
free α-MEM containing 15 µl of siPORT NeoFX for 10 min. The complex was 
added to the empty 60 mm culture plate and then cardiomyocytes (1 x 105 cells per 
plate) was overlayed onto the culture plate wells containing transfection complexes. 
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Transfected cells were incubated in normal cell culture conditions until ready for 
assay.  
 
4. Immunocytochemistry 
 
Cells were grown on 4-well plastic dishes (SonicSeal Slide, Nalge Nunc, 
Rochester, NY, USA). Following incubation, The cells were washed twice with PBS 
and then fixed with 4% paraformaldehyde in 0.5 ml PBS for 30 min at room 
temperature. The cells were washed again with PBS and then permeabilized for 30 
min in PBS containing 0.2% triton. The cells were then blocked in PBS containing 
10% goat serum and then incubated for 1 hr with rabbit polyclonal HA antibody. The 
cells were rewashed three times for 10 min with PBS and incubated with FITC-
conjugated goat anti-rabbit antibody as the secondary antibody for 1 hr. Photographs 
of cells were taken under fluorescence by immunofluorescence microscopy (Olympus, 
Melville, NY, USA). All images were made by using an excitation filter under 
reflected light fluorescence microscopy and transferred to a computer equipped with 
MetaMorph software ver. 4.6 (Universal Imaging Corp.).  
 
6. Statistical analysis 
 
Results are expressed as mean ± SEM. Statistical analysis as performed by 
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student’s t-test. Relationships were considered statistically significant when p value 
was less than 0.05. 
 
III. RESULTS  
 
1. Selectivity of adrenoceptors in protein synthesis and DNA 
 
In cardiomyocytes, protein synthesis was widely used as an index for the 
hypertrophic phenotype. To confirm selectivity of adrenoceptors in neonatal 
cardiomyocytes, cells were pretreated for 30 min with α1 selective antagonist 
prazosin (100nM) and β1 selective antagonist propanol (2µΜ). After 48 hr of 
stimulation with norepinephrine, total protein content/DNA ratios were estimated. 
Norepinephrine significantly increased the protein/DNA ratio by about  130% 
compared to the control of no treatment. In addition, pretreatment of the α1-
antagonist, prazocin suppressed the increase of the protein/DNA ratio but 
pretreatment of a β-antagonist did not (Figure 1). These data showed that the 
observed hypertrophy in neonatal cardiomyocytes was mediated mainly by α1-AR 
stimulation.  
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Figure 1. Norepinephrine-induced increase of protein synthesis in 
cardiomyocytes. After pretreatment with prazosin (PRA) (100 nM) or 
propranolol (PRO) (2 µM), cardiomyocytes were stimulated by 
norepinephrine (NE) (10−6 M) for 48hr. Total protein content was 
measured using a bicinchoninic acid (BCA) protein assay and 
evaluated as a ratio with DNA contents. P <0.05, when compared with 
the control value. 
 
2. Identification of α1-adrenoceptor mediated hypertrophic response  
 
To further confirm the selectivity of α1-adrenoceptor in norepinephrine-induced 
hypertrophy, changes of the expression of myosin heavy chain and the constitutive 
gene, myosin light chain-2v were detected by immumofluorescence images and 
RT-PCR, respectively. Norepinephrine is known to increase cell surface area and 
expression of genes encoded sarcomeric proteins and β-MHC, MLC-2v and α-
skeletal actin, fetal gene are augmented in cardiac hypertrophy. When cardiac 
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hypertrophy occurs as a result of many stimuli including norepinephrine, several 
genes such as α-MHC, cardiac α-actin are transformed into β-MHC and α-skeletal 
actin.34 We found that prolonged norepinephrine stimulation significantly increased 
cell surface area and expression of MLC-2v mRNA. In addition, norepinephrine-
induced hypertrophy was reduced to basal control level by α1 selective antagonist 
prazosin (Figure 2). We interpret these results to mean that hypertrophic responses 
including protein synthesis and reorganization of actin cytoskeleton were induced 
by α1-adrenoceptor stimulation in neonatal cardiomyocytes. 
 
Figure 2. Identification of phenotypic response and mRNA expression 
of cardiomyocytes to norepinephrine treatment. Immunofluorescence 
images were obtained by confocal microscope after 48 hr treatment 
with 10 (-6M) NE (×100). mRNA expression is represented by 
densitometrical analysis (ratio MLC-2v/GAPDH). P <0.05, when 
compared with the control value. 
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3. Effect of upstream regulators of ERKs activation in cardiomyocytes stimulated 
by norepinephrine 
 
The activation of MAPKs is important as a mediator of cardiac hypertrophy but 
also provide a sensitive and quantitative marker in noncardiac cell lines.35 
Norepinephrine is able to stimulate ERK1,2 activity in cardiomyocytes.36 In this study, 
the phosphorylation of ERKs (42 and 44 kDa) were upregulated following treatment 
with 10 (−6M) norepinephrine for 10 min. The activation of ERKs was inhibited by 
preincubation with α1-AR selective antagonist prazosin (100 nM, 30 min) but not β1-
AR selective antagonist propranolol. The inhibition pattern of MEK1, 2, upstream 
regulrator of ERKs was coincident with that of ERKs (Figure 3). These results show 
that intracellular signaling pathway induced norepinephrine is primarily processed by 
MEK1, 2/ERKs cascade through α1-AR in neonatal cardiomyocytes. 
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Figure 3. Activity of extra-cellular signal-regulated kinase (ERKs) and 
MEK1,2 upstream regulators of ERKs, in response to norepinephrine in 
neonatal rat cardiomyocytes. Activities of ERKs and MER1,2 were 
detected by immunoblot and their relative responses were based on a basal 
control level. P <0.05, when compared with the control value. 
 
4. Inhibitory effect of Gh by siRNA transfection in cardiac hypertrophy 
 
Several reports have demonstrated the involvement of Gh, in addition to Gαq, in 
α1AR-induced hypertrophy. To further confirm this association, we estimated the 
activation level of ERKs after treatement with siRNA for Gh was treated. Western 
blot analysis showed that RNA interference inhibits the expression of Gh protein. The 
ERKs activation increased by norepinephrine was not decreased by propranolol but 
inhibition of Gh resulted in down-regulated ERK activation to the control level. The 
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result indicated that Gh partially mediated the α1-AR stimulation by norepinephrine.  
 
 
 
 
 
Figure 4. Inhibition of Gh expression by siRNA for Gh inhibited 
norepinephrine stimulated hypertrophy in cardiomyocytes. Neonatal 
cardiomyocytes were transfected with siRNA to a final concentration 
of 10nM or vehicle. After pretreatment with propranolol (2µM), 
cardiomyocytes was stimulated by 10-6M norepinephrine for 10 min. 
Each signal was detected by immunoblot analysis using anti-ERK 
antibody and was quantified by densitometrical analysis. P <0.05, 
when compared with the control value.  
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5. Integrin-mediated signal transduction in hypertrophic cardiac myocytes 
 
To determine whether β1-integrin is coupled to cardiomyocyte hypertrophy 
via norepinephrine, the expression level of β1-integrin was examined after 
pretreatment with α1/ β-antagonist and siRNA for Gh. Although β1-integrin 
expression increased about 3 fold after the stimulation with norepinephrine, 
expression decreased after prazosin pretreatment and Gh inhibition. The pattern of 
β1-integrins expression was similar to that of ERKs activation. The similarity 
between β1-integrin expression patterns and phosphorylation of ERKs 
demonstrates that β1-integrin relates α1-adrenoceptor mediated hypertrophic 
response in cardiomyocytes and β1-integrin might correlate with Gh pathway.  
 
 
 
Figure 5. β1-integrins participate in the hypertrophic response of 
cardiomyocytes. β1-integrins were estimated by immunoblot assay and 
quantified by densitometrical analysis. P <0.05, when compared with 
the control value. 
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6. Effect of Gh and β1 integrin on hypertrophic response in NE-stimulated 
cardiomyocytes 
 
Previous data have showen that Gh and β1 integrin are related to cardiac 
hypertrophy. We investigated other factors influencing the hypertrophic response in 
addition to phosphorylation level of ERKs. It has been documented that β1 integrin 
participate in the hyeprtrophic response by β1 integrin overexpression.37 After Gh 
and β1 integrin was individually blocked by RNA interference, MLC-2v typically 
constitutive gene of cardiomycoytes, was examined by RT-PCR. Western blot 
analysis showed that the expression of β1 integrin was inhibited by RNA 
interference. The level of MLC-2v mRNA was increased with norepinephrine 
treatment and significantly reduced by inhibition of Gh and β1 integrin about to 
basal level (Figure 6).  
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Figure 6. Effect of Gh and β1 integrin on hypertrophic response in norepinephrine-
stimulated cardiomyocytes. Carciomyocytes was treated siRNA for 12 hr to block 
each gene , then incubated for 10min with 10µM norepinephrine, followed by 12 hr 
with media containing 0.1% FBS.  
  
 
 
7. Regulation of Gh and β1 integrin for downstream factors in NE-stimulated 
cardiomyocytes 
In general, the cytoplasmic protein tyrosine kinase focal adhesion kinase (FAK) 
is activated by many factors including growth factors or G-protein coupled receptor 
and plays an important role in mechanism of integrin-dependent adhesion on the 
ECM. To examine whether FAK might be associated with the hypertrophic 
signaling pathway through α1-AR, phosphorylation of FAK was measured after Gh 
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or β1-integrin expression was inhibited by siRNA treatment. Treatment of 
cardiomyocte with 10 µM NE for 10 min enhanced the phosphorylation of FAK but 
FAK activity was prevented in spite of norepinephrine stimulation by inhibition of 
each gene (Figure 7).  
 
 
 
Figure 7. Effect of Gh and β1 integrin on FAK activation in 
norepinephrine-stimulated cardiomyocytes.  
 
Shc, a regulator of FAK, was also examined by flow cytometry. Expression of Shc 
was increased to 2 fold relative to the basal level, and reduced by siRNA treatment 
for Gh and β1-integrin (Figure 8). These results suggest that both Gh and β1-integrin 
can affect hypertrophic responses via the Shc and FAK signaling pathway.   
 
 - 22 - 
 
Figure 8. Effect on Gh and β1 integrin on Shc expression in NE-
stimulated cardiomyocytes. Shc expression was analyzed by flow 
cytometry with anti-Shc integrin antibody. 
 
 
IV. DISCUSSION 
 
Cardiac hypertrophy is related to an increased risk of cardiac arrhythmias, 
diastolic dysfunction, congestive heart failure, and death2,3 and is a compensatory 
process which occurs in pathological conditions, such as hypertension, myocardial 
infarction, and some genetic heart diseases.3 Although many previous studies have 
underlined the relationship of Gαq and Gα12/13  with hypertrophy in 
cardiomyocytes,61 Some groups have been recently reported that cardiac 
hypertrophy by α1-AR stimulation was also related to the Gh pathway.39,40,41,42 
The relationship between increased adrenergic activity and cardiac hypertrophy has 
been documented for quite a some time, but the mechanisms have not been clearly 
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understood until recent studies. The present study shows that norepinephrine 
induces cardiac hypertrophy through α1-AR stimulation and Gh is partially 
mediated hypertrophy through β1 integrin/MEK1,2/ERKs pathway. It is first 
demonstrated that Gh-coupled receptor was related to β1 integrin in cardiomyocytes 
except chondrocytes.  
In neonatal cariomyocytes, α1-AR mediation plays an important role in 
hypertrophic response. In the current study, confocal microscopy was widely 
applied to prove that adrenergic stimulation caused significant increases in the cell 
volume of cultured cardiomyocytes. Figure 1 and 2 demonstrate that the selectivity 
of adrenoceptors in cardiac hypertrophy has an effect on protein synthesis and 
estimation of constitutive gene MLC-2 and MHC. 
Cardiac hypertrophy altered the phosphorylation of both ERK 1, 2 and their 
upstream regulator MEK 1,2 which is important because the change of MAPK is an 
important result of hypertrophy (Figure 3). We demonstrated through RNA 
interference experiment that Gh might be related to cardiac hypertrophy (Figure 4). 
Tushi et al62 and Lee et al63 showed PLC might be a key component in initiation of 
the cardiomyocytes hypertrophic response. Protein synthesis was attenuated by 
PLC inhibitor, U73122 in a concentration dependent manner and DAG formation 
was decreased. In addition, PLC-δ1 mediates the signal pathway through Gh-
coupled receptor signaling.63 
Many stimuli are known to promote cardiac hypertrophy including endothelin-1 
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(ET-1), phenylepinephrine, and norepinephrine. Such agonists stimulate cellular 
signaling pathway via protein kinase cascade. Protein kinase cascade also activates 
the extra-cellular signal-regulated protein kinase 1, 2 (ERK 1, 2), subfamily of 
MAPKs.  
Although integrins were initially regarded as necessary molecules for adhesive 
interactions between cells and the ECM, present studies have indicated that integrins 
might be bidirectional signaling molecules.59 Glembotski et al. examined the 
regulatory role of β1 integrins in the hypertrophic response of adrenergically 
stimulated NRVMs because β1 integrins are abundant in the cardiac cell.60 Figure 5 
and Figure 6 firmly demonstrate that β1-integrin is related to cardiomyocyte 
hypertrophy. Ross et al showed that overexpression of β1 integrins in cardiomyocytes 
increased hypertrophic marker gene expression and protein synthesis but had no 
effect on cellular DNA synthesis. Likewise, inhibition of integrin signaling 
downregulated the adrenergically stimulated hypertrophic gene response.59 Our results 
are in agreement with our these data.  
β1 integrin induced focal adhesion formation at focal adhesion sites. Focal 
adhesion complexes including FAK, Src, cytoskeletal proteins and signal transduction 
molecules can directly regulate transcription and translation.64,65,66 Figure 7 and Figure 
8 show that such signaling molecules are directly related to both integrin and Gh 
protein.  
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V. CONCLUSIONS 
 
In conclusion, we found that Gh partially mediated the α1-AR stimulation by 
norepinephrine. We linked β1 integrin signaling to the hypertrophic pathway in a 
cellular model using α1 adrenergic specific stimulation of neonatal cardiomyocytes. 
Finally, this study was the first to evaluate whether the hypertrophic response 
induced by norepinephrine in cardiomyocytes occurs through β1 
Integrin/Shc/FAK/MEK1, 2/ERKs signal pathways via α1-AR/Gh. 
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국문 요약 ( In Korean ) 
Interaction of α-adrenergic stress and integrin-mediated signal transduction  
in hypertrophic cardiac myocytes 
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변 기 현 
 
심근세포에서 alpha(1)-adrenoceptor(AR)의 자극은 심근비대를 
유발한다. Gh 단백질(transglutaminase II, TGII)는 tissue type 
transglutaminase이며 GTPase 활성을 통해 alpha(1B)-adrenoceptor 
신호를 전달한다. 최근에, G 단백질뿐만 아니라 인테그린 활성화는 
심근세포의 생장에 필수적일 수 있다. 여기서 우리 연구의 목적은 
활성화된 Gh와 integrin이 상호 반응하여 심근세포의 비대 반응을 
야기하는지를 검증하고 Gh 결정인자와 관련된 하위 신호전달 체계를 
규명하는 것이다. 첫째, 우리는 MLC-2와 MHC 구조 유전자의 측정과 
단백질 합성에 의해 norepinephrine(NE)에 의해 야기된 심장 
비대증에서 α-adrenoceptor의 특이성을 관찰하였다. NE에 의한 
심장비대 반응은 ERK1,2와 이들의 상위조절자인 MEK1,2를 
활성화시키나 이들은 Gh에 대한 siRNA 처리에 의해 억제된다. 우리는 
또한 NE에 의한 심장비대증에서 β1-integrin의 상당한 활성화를 
관찰하였다. 게다가, NE에 의해 야기되는 심근세포의 비대에서 FAK과 
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이것의 조절자인 Shc는 직접적으로 integrin β1과 Gh 단백질과 
연관되어 있다. FAK과 Shc의 활성화는 Gh에 대한 siRNA처리로 억제할 
수 있다. 결론적으로, norepinephrine에 의한 심근세포의 비대는 α1-
AR/ Gh를 거쳐서 β1 Integrin/Shc/FAK/MEK1,2/ERKs 신호 전달체계를 
통해 일어난다.   
___________________________________________________________________ 
핵심되는 말 : 심근세포: 비대: 인테그린: 알파 교감신경 수용체 
 
